Plain-English translation of NCT06473623 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a treatment called auricular fiber vagus nerve stimulation (afVNS)—a non-invasive device that you wear on your ear to stimulate a nerve. Researchers want to see if this treatment can help reduce autism symptoms and related challenges like anxiety or sleep problems. The study will track how well the device works and how tolerable it is when used at home.
Many people with autism struggle with anxiety, sleep issues, and other symptoms that are hard to treat with current options. This trial exists to explore whether stimulating a specific nerve through the ear could offer a new, non-invasive way to help manage these challenges.
You likely qualify if…
You likely don't qualify if…
You would use the non-invasive ear device at home for one hour each day over 14 days following a set stimulation plan. Before and after this two-week period, you'll complete questionnaires and assessments to measure changes in autism symptoms, anxiety, sleep quality, and other areas. A total of 20 participants will be enrolled in this study.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
Hong Kong
Neuropix
Enrollment target
~20 participants
Started
December 2025
Primary completion
February 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
7 Years – 26 Years
Last updated on clinicaltrials.gov in January 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Daniel Ko, PhD
Neuropix
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.